Debbie Rigby rounds up the latest in research news Real-world safety of concomitant colchicine and statin therapy Colchicine is widely used in the management of gout and familial Mediterranean fever. …

Certainty provided by the 8CPA “has set up community pharmacy nicely” in the eyes of bankers, the AJP Podcast hears  Westpac’s national general manager of specialised industries, Belinda Hegarty, discusses financing …

A Chemist Warehouse pharmacy refused to dispense on a fraudulent script presented by a doctor in his own name A doctor forged a prescription for the purpose of obtaining oxycodone …

Australian researchers say their new study supports an increase in medicines reviews, particularly those conducted by pharmacists An estimated 2.3 million older Australians are being dispensed multiple medicines associated with …

The PSA has announced that it has awarded Georgia Muir, from Griffith University, the Professor James Dare Pharmacy Graduate of the Year Award Each year, every School of Pharmacy in …

Changes to PBS restrictions for atomoxetine and guanfacine for the treatment of ADHD are being supported by the PBAC  The Pharmaceutical Benefits Advisory Committee (PBAC) is backing a move to broaden access …

Leaving it late to submit a valid licensing application will create unnecessary risk and avoidable compliance issues, pharmacy owners in Queensland are being warned  Proprietors who fail to apply to the Queensland …

Raven’s Recruitment operations manager David Shaw looks at the questions pharmacists should ask before accepting a new role A pharmacist reads an advertisement promising expanded scope, a consulting room and …

Eli Lilly’s direct-to-consumer distribution model and the recall of Andrographis products continued to attract headlines this week  Reassurances from pharmaceutical giant Eli Lilly are doing little to ease pharmacists’ concerns …

A Toyota LandCruiser Prado which smashed its way metres into a pharmacy missed patients by mere seconds in what the pharmacy co-owner says is a “miracle” Pharmacist Vince Pappalardo, who …

Prescribers are being urged not to initiate treatment with Tavneos (avacopan) in new patients, with the drug to be withdrawn from the Australian market next year  CSL Seqirus is set …